Abstract:Gut microbiota is a complex system of organisms, mainly different bacterial species, the gut microbiota interacts with the host, affects host systems and organs (e.g. the brain) and modulates the host physiological functions. The interaction between the gut microbiota and the brain, famously known as gut‐brain axis is a bidirectional connection via neural, immune, and endocrine pathways.IntroductionObesity is a major health problem that is associated with many physiological and mental disorders, such as diabetes, stroke, and depression. Gut microbiota has been affirmed to interact with various organs, including the brain. Intestinal microbiota and their metabolites might target the brain directly via vagal stimulation or indirectly through immune‐neuroendocrine mechanisms, and they can regulate metabolism, adiposity, homoeostasis and energy balance, and central appetite and food reward signaling, which together have crucial roles in obesity. Studies support the concept of bidirectional signaling within the gut–brain axis (GBA) in the pathophysiology of obesity, mediated by metabolic, endocrine, neural, and immune system mechanisms.Materials and methodsScopus, PubMed, Google Scholar, and Web of Science databases were searched to find relevant studies.ResultsThe gut–brain axis (GBA), a bidirectional connection between the gut microbiota and brain, influences physiological function and behavior through three different pathways. Neural pathway mainly consists of the enteric nervous system (ENS) and vagus nerve. Endocrine pathway, however, affects the neuroendocrine system of the brain, particularly the hypothalamus–pituitary–adrenal (HPA) axis and immunological pathway. Several alterations in the gut microbiome can lead to obesity, by modulating metabolic pathways and eating behaviors of the host through GBA. Therefore, novel therapies targeting the gut microbiome, i.e., fecal microbiota transplantation and supplementation with probiotics and prebiotics, can be a potential treatment for obesity.ConclusionThis study corroborates the effect of gut microbiome on physiological function and body weight. The results show that the gut microbiota is becoming a target for new antiobesity therapies.

Obesity and the gut microbiota: implications of neuroendocrine and immune signaling

Microbiome–Gut Dissociation: Investigating the Origins of Obesity

The Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis

Gut microbiota in obesity and metabolic disorders

Importance of gut microbiota in obesity

Microbiota, inflammation and obesity

Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function

Gut microbiota and obesity: New insights

Understanding the role of the human gut microbiome in overweight and obesity

From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets

Obesity and Its Multiple Clinical Implications between Inflammatory States and Gut Microbiotic Alterations

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

Probiotics and Gut Microbiota in Obesity: Myths and Realities of a New Health Revolution

The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts

Obesity Affects the Microbiota–Gut–Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators

Gut Microbiota and Obesity: The Chicken or the Egg?

The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease

The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications

The microbiome's influence on obesity: mechanisms and therapeutic potential

Obesity and gut–microbiota–brain axis: A narrative review

The Role of Gut Microbiota in the Onset and Progression of Obesity and Associated Comorbidities